article thumbnail

Summing up the STAR*D Scandal: The Public was Betrayed, Millions were Harmed, and the Mainstream Media Failed Us All

Mad in America

American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct. There was one other red flag.

article thumbnail

Stop Using Antidepressants Except for “the Most Severe Depression,” Experts Say

Mad in America

Take, for instance, a recent meta-analysis finding that exercise is just as good as antidepressants at treating mild to moderate depression —and that adding drugs to the regimen does not improve outcomes. But depression—in its natural state—is self-limiting.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Winding Back the Clock: What If the STAR*D Investigators Had Told the Truth?

Mad in America

Here is the cover from that issue: In his essay, Miller repeatedly stressed that ever since 2006, the STAR*D study had stood “out as a beacon guiding treatment decisions.” Posternak published his findings in 2006, a few months before the STAR*D investigators published their summary results.

article thumbnail

The New York Times Is Now Engulfed in the STAR*D Scandal

Mad in America

That is the bottom-line outcome that the STAR*D investigators promoted to the public in November 2006, when it published a summary of the study outcomes in the American Journal of Psychiatry. Then, in November 2006, they published a summary report of outcomes. However, it is not a story of advance that has survived the test of time.

article thumbnail

It’s You, It’s Not Me: Treatment Resistant Depression and the Psychiatric Breakup

Mad in America

The eighties and nineties were a depression-treatment renaissance. Strategies and Tactics in the Treatment of Chronic Depression. Treatment-resistant depression reconsidered. Souery, Daniel, Papakostas, George, Trivedi, Madhukar, Treatment-Resistant Depression (2006). billion worldwide.

article thumbnail

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

Psychiatric News reported in 2024 that PubMed shows more than 400 trials of ketamine as a depression treatment in the past decade; however, it also reports that G. The same disregard for the scientific method that establishment psychiatry evidenced in standard antidepressant drug trials is now evident with ketamine.

article thumbnail

STAR*D: The Harms of Orchestrated Psychiatric Fraud

Mad in America

A few years ago, one in five US adults reported having ever received a diagnosis of depression. At a cost of 35 million dollars, NIMH’s STAR*D study, which was published in 2006 , is the most extensive and expensive study ever conducted to determine the effectiveness of drug treatment for depression.